Arimidex and Bone loss

[John Benz]

From www.curetoday.com a website for cancer patients and survivors.

Link to the complete article

http://www.curetoday.com/currentissu...re3/index.html


Although anyone receiving chemotherapy can experience bone loss, it occurs most commonly in those who undergo hormone-modifying treatments. These comprise aromatase inhibitors, such as Arimidex (anastrozole), Femara (letrozole), and Aromasin (exemestane), for postmenopausal women; removing or shutting down the ovaries in premenopausal women; and androgen deprivation therapy, which involves removing the testicles or treatment with luteinizing hormone-releasing hormone (LHRH) analogs and LHRH antagonists, for men with prostate cancer. Estrogen in men and women and androgens (including testosterone) in men play key roles in maintaining a healthy balance between bone-building osteoblasts and bone-eating osteoclasts.

I believe Chemo plays a large part in this I just found the article interesting.